ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

937.4000 2.70 (0.29%)

NSE Jun 23, 2025 10:28 AM

28.11% Fall from 52W High

Volume: 21,265

Alembic Pharmaceuticals Ltd.

27 Sep 2024

937.40

0.29%

Company Update

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals receives USFDA Final Approval for Paliperidone Extended - Release Tablets.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market opens lower, Bharat Electronics bags multiple orders worth Rs 585 crore

Trendlyne Marketwatch | 23 Jun 2025, 10:22AM

Five Interesting Stocks Today - June 20, 2025

The Baseline | 20 Jun 2025

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals

| 22 Jul 2020, 06:11PM